Prudential Financial Inc Dr Reddys Laboratories LTD Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Prudential Financial Inc holds 38,600 shares of RDY stock, worth $540,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,600

Previous 32,009 20.59%

Holding current value

$540,786

Previous $2.44 Million 25.76%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$75.41 - $84.21 $497,027 - $555,028	6,591 Added 20.59%	38,600 $3.07 Million
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $1,092 - $1,219	-16 Reduced 0.05%	32,009 $2.44 Million
Q1 2024 May 14, 2024	SELL	$67.36 - $77.59 $76,588 - $88,219	-1,137 Reduced 3.43%	32,025 $2.35 Million
Q4 2023 Feb 13, 2024	SELL	$64.27 - $69.9 $25,258 - $27,470	-393 Reduced 1.17%	33,162 $2.31 Million
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $447,846 - $526,490	-7,235 Reduced 17.74%	33,555 $2.24 Million
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $72,542 - $85,829	-1,360 Reduced 3.23%	40,790 $2.57 Million
Q1 2023 May 12, 2023	SELL	$51.63 - $56.93 $240,699 - $265,407	-4,662 Reduced 9.96%	42,150 $2.4 Million
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $63,323 - $71,123	-1,238 Reduced 2.58%	46,812 $0
Q3 2022 Nov 04, 2022	BUY	$49.9 - $57.32 $288,422 - $331,309	5,780 Added 13.67%	48,050 $2.52 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $39,696 - $46,504	800 Added 1.93%	42,270 $2.34 Million
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $98,663 - $133,371	-2,044 Reduced 4.7%	41,470 $2.31 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $5,950 - $6,725	-100 Reduced 0.23%	43,514 $2.85 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $680,147 - $850,777	11,300 Added 34.97%	43,614 $2.84 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $73,674 - $88,001	-1,186 Reduced 3.54%	32,314 $2.38 Million
Q1 2021 May 12, 2021	SELL	$57.98 - $73.08 $3.32 Million - $4.19 Million	-57,324 Reduced 63.12%	33,500 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $652,145 - $742,556	-10,416 Reduced 10.29%	90,824 $6.48 Million
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $1.78 Million - $2.51 Million	34,700 Added 52.15%	101,240 $7.04 Million
Q2 2020 Aug 12, 2020	SELL	$39.55 - $54.65 $411,319 - $568,360	-10,400 Reduced 13.52%	66,540 $3.53 Million
Q1 2020 May 12, 2020	SELL	$34.75 - $45.85 $100,775 - $132,965	-2,900 Reduced 3.63%	76,940 $3.1 Million
Q4 2019 Feb 11, 2020	BUY	$36.66 - $41.78 $327,740 - $373,513	8,940 Added 12.61%	79,840 $3.24 Million
Q3 2019 Nov 13, 2019	SELL	$34.82 - $39.26 $2.2 Million - $2.48 Million	-63,200 Reduced 47.13%	70,900 $2.69 Million
Q2 2019 Aug 08, 2019	SELL	$36.05 - $42.76 $850,779 - $1.01 Million	-23,600 Reduced 14.97%	134,100 $0
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $261,121 - $296,161	7,300 Added 4.85%	157,700 $0
Q4 2018 Feb 07, 2019	BUY	$31.89 - $38.44 $1.27 Million - $1.53 Million	39,800 Added 35.99%	150,400 $5.67 Million
Q3 2018 Nov 07, 2018	SELL	$29.25 - $36.73 $1.15 Million - $1.44 Million	-39,300 Reduced 26.22%	110,600 $0
Q2 2018 Aug 13, 2018	BUY	$28.49 - $35.06 $1.69 Million - $2.08 Million	59,200 Added 65.27%	149,900 $0
Q1 2018 May 04, 2018	SELL	$31.93 - $39.54 $332,072 - $411,216	-10,400 Reduced 10.29%	90,700 $0
Q4 2017 Feb 13, 2018	SELL	$34.15 - $37.62 $177,580 - $195,624	-5,200 Reduced 4.89%	101,100 $3.8 Million
Q3 2017 Nov 02, 2017	BUY	$30.11 - $37.72 $3.2 Million - $4.01 Million	106,300	106,300 $3.79 Million

Others Institutions Holding RDY

# of Institutions

250

Shares Held

33.5M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.33B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Dr Reddys Laboratories LTD Transaction History